Oncolytics Biotech(R) Reports 2019 Second Quarter Financial Results and Operational Highlights
Co-development agreement with Pfizer and Merck KGaA to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and...
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency